| Autor: |
Oliveira ML; Instituto de Química, Universidade de São Paulo, SP, Brasil., Roberts TM, Druker BJ, Armelin MC |
| Jazyk: |
angličtina |
| Zdroj: |
Oncogene [Oncogene] 1998 Jun 11; Vol. 16 (23), pp. 2975-82. |
| DOI: |
10.1038/sj.onc.1201841 |
| Abstrakt: |
Cell transformation by Polyomavirus middle T (MT) oncoprotein involves binding and activation of several cytoplasmic proteins that participate in growth factors-induced mitogenic signal transduction to the nucleus. We have previously reported that the AP-1 transcriptional complex is a target for MT during cell transformation. To analyse the interactions between MT and cellular proteins that are required for constitutive AP-1 activation, we compared wild type and transformation-defective MT mutant cell lines. High AP-1 activity, assessed by gel mobility shift assays, displayed by MT-overexpressing cells, is dependent on MT binding to phosphatidylinositol-3 kinase (P13K). Treatment with wortmannin (a specific P13K inhibitor) leads to decreased AP-1 activity. Supershift and Western blot analysis with specific antisera, indicate that JunB and cJun, but not cFos or FosB are present in the AP-1 complex. The results confirm the AP-1 complex as a downstream MT target and indicate that AP-1 activation may not be sufficient for cell transformation, since two transformation-defective MT mutants (250phe and MT322) display high AP-1 activity. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
